SC14D9C

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14D-9

(Rule 14d-101)

Solicitation/Recommendation Statement

Under Section 14(d)(4) of the Securities Exchange Act of 1934

 

 

FOUNDATION MEDICINE, INC.

(Name of Subject Company)

 

 

FOUNDATION MEDICINE, INC.

(Name of Person Filing Statement)

 

 

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

 

 

350465100

(CUSIP Number of Class of Securities)

 

 

Michael Pellini, M.D.

President and Chief Executive Officer

Foundation Medicine, Inc.

150 Second Street

Cambridge, MA 02141

(617) 481-2200

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications

on Behalf of the Person Filing Statement)

With copies to:

Stuart M. Cable, Esq.

Lisa R. Haddad, Esq.

Kingsley L. Taft, Esq.

Goodwin Procter LLP

Exchange Place

Boston, MA 02109

(617) 570-1000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications

on Behalf of the Person Filing Statement)

 

 

 

x   Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

The information set forth under Item 1.01 of the amendment to the Current Report on Form 8-K filed by Foundation Medicine, Inc. on February 2, 2015 (including all exhibits attached thereto) is incorporated herein by reference.